CVE-2022-4731 myapnea Title cross site scripting
Attackers can inject malicious scripts via the Title Handler in myapnea, potentially executing code in victim browsers.
- Exploited in the wild
- Not known
- Login needed
- An administrator
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- None listed
What is CVE-2022-4731?
CVE-2022-4731 is a low-severity cross-site scripting vulnerability in myapnea, published on 25 Dec 2022. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.
Official description
A vulnerability, which was classified as problematic, was found in myapnea up to 29.0.x. Affected is an unknown function of the component Title Handler. The manipulation leads to cross site scripting. It is possible to launch the attack remotely. Upgrading to version 29.1.0 is able to address this issue. The name of the patch is 99934258530d761bd5d09809bfa6c14b598f8d18. It is recommended to upgrade the affected component. VDB-216750 is the identifier assigned to this vulnerability.
Weakness: CWE-79
Which versions are affected by CVE-2022-4731?
It affects 1 product.
Products include Myapnea Myapnea.
How do I fix CVE-2022-4731?
No fix has been published for CVE-2022-4731 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2022-4731 being exploited?
There is no known exploitation of CVE-2022-4731 in the wild and no public exploit code.
Sources
Also known as GHSA-w774-x8gc-78vf.